Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Pancreatic Neoplasms 2 Neoplasms 1 Neoplasm Metastasis 1 Leiomyoma 1 Gastrointestinal Stromal Tumors 1

Interventions

pembrolizumab 105 Specimen Handling 55 Magnetic Resonance Spectroscopy 48 Biopsy 47 Nivolumab 39 Paclitaxel 35 Radiosurgery 30 Gemcitabine 30 Carboplatin 30 Cisplatin 23 Irinotecan 22 Ipilimumab 22 Cyclophosphamide 22 trastuzumab deruxtecan 21 Leucovorin 19 Capecitabine 19 Fluorouracil 18 Cetuximab 18 Bevacizumab 18 130-nm albumin-bound paclitaxel 18 Pemetrexed 17 Fulvestrant 17 Drug Therapy 16 Docetaxel 16 Taxes 15 Oxaliplatin 15 olaparib 14 abemaciclib 14 Radiotherapy 14 atezolizumab 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasm Metastasis × Endosonography × 1 year × Clear all

NCT06831136 2025-09-10

PANCARDINAL-2

The University of Texas Health Science Center, Houston

Phase 2 Recruiting

Neoplasm Metastasis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡